| |
| |
|
| Insider
Information: |
New Enterprise Associates 15, L.p. |
| Relationship: |
10% Owner |
| City: |
Timonium |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
52,208,097 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$151,994,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,208,097 |
|
|
| Total
Value |
$151,994,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
2017-01-27 |
9,064,574 |
|
0 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
2022-10-19 |
0 |
2022-10-19 |
0 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2021-05-24 |
4,520,019 |
2021-05-24 |
0 |
Premium* |
|
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
2021-06-08 |
19,263,413 |
2021-06-08 |
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
14,614,829 |
2022-11-16 |
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
4,745,262 |
2022-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
4,745,262 |
0 |
- |
|
| IONQ |
Ionq Ord Shs |
10% Owner |
– – • |
2022-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,691,864) |
14,614,829 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,952,957) |
0 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2022-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,952,957 |
3,952,957 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,952,957) |
0 |
0 |
- |
|
| DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
– – • |
2021-06-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,000,000) |
19,263,413 |
0 |
- |
|
| EAR |
Eargo, Inc. |
10% Owner |
– – • |
2021-05-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
4,520,019 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2019-04-08 |
4 |
B |
$1.14 |
$4,956,523 |
D/D |
4,347,827 |
25,243,865 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-21 |
4 |
B |
$1.49 |
$448,380 |
D/D |
300,000 |
20,896,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-20 |
4 |
B |
$1.63 |
$326,060 |
D/D |
200,000 |
20,596,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$1.98 |
$121,084 |
D/D |
61,200 |
20,396,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-10 |
4 |
B |
$1.98 |
$51,576 |
D/D |
26,000 |
20,334,838 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-07 |
4 |
B |
$1.98 |
$232,362 |
D/D |
117,100 |
20,308,838 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-06 |
4 |
B |
$1.99 |
$54,414 |
D/D |
27,300 |
20,191,738 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-30 |
4 |
B |
$1.98 |
$142,067 |
D/D |
71,900 |
20,164,438 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-28 |
4 |
B |
$1.99 |
$48,824 |
D/D |
24,500 |
20,092,538 |
2.37 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-20 |
4 |
B |
$1.98 |
$336,107 |
D/D |
170,000 |
20,068,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-19 |
4 |
B |
$1.88 |
$956,658 |
D/D |
510,000 |
19,898,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-16 |
4 |
B |
$1.86 |
$649,355 |
D/D |
350,000 |
19,388,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-15 |
4 |
B |
$1.86 |
$631,958 |
D/D |
340,000 |
19,038,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-08-21 |
4 |
B |
$2.26 |
$1,499,998 |
D/D |
663,716 |
18,698,038 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-07-19 |
4 |
B |
$2.00 |
$101,165 |
D/D |
50,600 |
18,034,322 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-07-18 |
4 |
B |
$1.95 |
$390,580 |
D/D |
200,000 |
17,983,722 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-06-28 |
4 |
B |
$2.10 |
$392,692 |
D/D |
187,130 |
17,783,722 |
2.45 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-06-27 |
4 |
B |
$2.15 |
$11,384 |
D/D |
5,295 |
17,596,592 |
2.37 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
